Prevalence and variability of HIV/AIDS-associated neurocognitive impairments in Africa: a systematic review and meta-analysis

Abstract

Abstracts Background HIV/AIDS-associated neurocognitive impairments negatively affect treatment adherence, viral load suppression, CD4 count, functionality, and the overall quality of life of people with seropositive status. However, huge variability is observed across primary studies regarding the prevalence and determinants of neurocognitive impairment in people with HIV/AIDS. This systematic review and meta-analysis sought to determine the pooled prevalence of neurocognitive impairment and identify factors contributing to variations in its estimate among people living with HIV/AIDS in Africa. Methods A comprehensive literature search of scientific databases (Medline/PubMed, SCOPUS, Web of Science, PsycINFO, and EMBASE) was performed from inception onward. Google and Google Scholar were also searched for grey literature. Research articles available until July 15, 2022 were included. We used STATA-version 14 statistical software for analysis. A random effect model was executed to pool the reported prevalence of neurocognitive impairments. Subgroup analysis was done to show variations in the prevalence of neurocognitive impairments and factors that might contribute to these variations. Results A literature search resulted in 8,047 articles. After the removal of duplications and thorough evaluation, a total of 49 studies were included in the meta-analysis. The prevalence of HIV/AIDS-associated neurocognitive impairments was highly variable across studies, ranging from 14% to 88%, yielding the pooled prevalence of HIV/AIDS-associated neurocognitive impairment to be 46.34% [95% CI (40.32, 52.36)] and I2 = 98.5% with a P-value of 0.001. Conclusions A large proportion of people living with HIV/AIDS in Africa have HIV/AIDS-associated neurocognitive impairment. This illustrates the need to establish practical approaches to early identification and effective control of HIV/AIDS-associated neurocognitive impairments. However, there were variabilities in the reported prevalence of HIV/AIDS-associated neurocognitive impairments across studies. This further demonstrates the need to have consistent measurement approaches. Trial registration PROSPERO 2022, “CRD42020166572”.

Prevalence and variability of restrictive care practice use (physical restraint, seclusion and chemical restraint) in adult mental health inpatient settings: A systematic review and meta‐analysis

“…Overall, this comprehensive systematic review identified the integrations/interrelation of different concepts, including study designs, definitions, measurement/data collection methods and reporting protocols to contribute to the variations in the data reported associated with proportions of people exposed to different forms of restrictive care practice use in adult mental health inpatients. For example, the choice of study design can influence the scope and depth of the data being collected, which in turn, can impact the reported proportion estimates the measurement outcome (Mekuriaw et al., 2023). Furthermore, the review highlights the significance of definitions and classification taxonomies in shaping the data reported regarding the proportion estimates of RCP use.…”

Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system

“…For instance, a recent systematic review and meta-analysis reported a range of HAND prevalence between 14% and 88% in African countries. 22 The high prevalence of HAND in Africa may be attributed to several factors. These include delayed initiation of ART and inadequate health system coverage leading to poor ART adherence, and reduced surveillance and diagnosis of comorbidities or coinfections affecting the CNS.…”

“…The prevalence of HAND varies depending on the population enroled in the study, reflecting these multifactorial inputs. For instance, a recent systematic review and meta‐analysis reported a range of HAND prevalence between 14% and 88% in African countries 22 . The high prevalence of HAND in Africa may be attributed to several factors.…”

HIV subtypes and molecular transmission characteristics among elderly HIV-infected individuals aged 50 and above: a cross-sectional study in Huzhou City, Eastern China

“…8 HIV is an RNA virus characterised by a highly variable genome that gives rise to a multitude of types worldwide. 9 HIV-infected individuals are at risk of coinfection with multiple HIV subtypes, leading to the recombination of genes in host cells and the subsequent emergence of novel circulating recombinant forms (CRFs). 10 Furthermore, a small fraction of the viral genome undergoes recombination events that give rise to unique recombinant forms.…”